Reducing patient risk for human papillomavirus infection and cervical cancer

Jennifer Herbert, Janis Strickland Coffin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The majority of cervical cancers result when the human papillomavirus (HPV) is transmitted from a man to a woman during vaginal intercourse. Several factors, including vaginal intercourse at an early age or with multiple sex partners, place women at increased risk for infection with HPV. It is important for physicians to be aware of these risk factors and to screen for them in all of their female patients. It is also important for physicians to be familiar with the new HPV vaccinations that are becoming available, such as Gardasil, which in June 2006 became the first vaccine approved by the US Food and Drug Administration to protect patients against cervical cancer. The widespread use of routine HPV screening and cervical cancer vaccines can be expected to decrease the incidence of new HPV infection and cervical cancer worldwide.

Original languageEnglish (US)
Pages (from-to)65-70
Number of pages6
JournalJournal of the American Osteopathic Association
Volume108
Issue number2
StatePublished - Feb 1 2008

Fingerprint

Papillomavirus Infections
Uterine Cervical Neoplasms
Physicians
Cancer Vaccines
Sexual Partners
United States Food and Drug Administration
Vaccination
Vaccines
Incidence
Infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Reducing patient risk for human papillomavirus infection and cervical cancer. / Herbert, Jennifer; Coffin, Janis Strickland.

In: Journal of the American Osteopathic Association, Vol. 108, No. 2, 01.02.2008, p. 65-70.

Research output: Contribution to journalArticle

@article{7fc4ea26f99b4338a2f26f3d08d3c9f1,
title = "Reducing patient risk for human papillomavirus infection and cervical cancer",
abstract = "The majority of cervical cancers result when the human papillomavirus (HPV) is transmitted from a man to a woman during vaginal intercourse. Several factors, including vaginal intercourse at an early age or with multiple sex partners, place women at increased risk for infection with HPV. It is important for physicians to be aware of these risk factors and to screen for them in all of their female patients. It is also important for physicians to be familiar with the new HPV vaccinations that are becoming available, such as Gardasil, which in June 2006 became the first vaccine approved by the US Food and Drug Administration to protect patients against cervical cancer. The widespread use of routine HPV screening and cervical cancer vaccines can be expected to decrease the incidence of new HPV infection and cervical cancer worldwide.",
author = "Jennifer Herbert and Coffin, {Janis Strickland}",
year = "2008",
month = "2",
day = "1",
language = "English (US)",
volume = "108",
pages = "65--70",
journal = "The Journal of the American Osteopathic Association",
issn = "0098-6151",
publisher = "American Osteopathic Association",
number = "2",

}

TY - JOUR

T1 - Reducing patient risk for human papillomavirus infection and cervical cancer

AU - Herbert, Jennifer

AU - Coffin, Janis Strickland

PY - 2008/2/1

Y1 - 2008/2/1

N2 - The majority of cervical cancers result when the human papillomavirus (HPV) is transmitted from a man to a woman during vaginal intercourse. Several factors, including vaginal intercourse at an early age or with multiple sex partners, place women at increased risk for infection with HPV. It is important for physicians to be aware of these risk factors and to screen for them in all of their female patients. It is also important for physicians to be familiar with the new HPV vaccinations that are becoming available, such as Gardasil, which in June 2006 became the first vaccine approved by the US Food and Drug Administration to protect patients against cervical cancer. The widespread use of routine HPV screening and cervical cancer vaccines can be expected to decrease the incidence of new HPV infection and cervical cancer worldwide.

AB - The majority of cervical cancers result when the human papillomavirus (HPV) is transmitted from a man to a woman during vaginal intercourse. Several factors, including vaginal intercourse at an early age or with multiple sex partners, place women at increased risk for infection with HPV. It is important for physicians to be aware of these risk factors and to screen for them in all of their female patients. It is also important for physicians to be familiar with the new HPV vaccinations that are becoming available, such as Gardasil, which in June 2006 became the first vaccine approved by the US Food and Drug Administration to protect patients against cervical cancer. The widespread use of routine HPV screening and cervical cancer vaccines can be expected to decrease the incidence of new HPV infection and cervical cancer worldwide.

UR - http://www.scopus.com/inward/record.url?scp=40349102081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40349102081&partnerID=8YFLogxK

M3 - Article

C2 - 18303060

AN - SCOPUS:40349102081

VL - 108

SP - 65

EP - 70

JO - The Journal of the American Osteopathic Association

JF - The Journal of the American Osteopathic Association

SN - 0098-6151

IS - 2

ER -